Results 151 to 160 of about 242,018 (254)

Adverse Effects of Low Serum HDL-C Levels on Prognosis and Tumor Immune Microenvironment in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia. [PDF]

Cancer Med
Lv W, Liu S, Song J, Liang Z, Liao H, Huang Q, Zhu Z, Mo Z, Wang Y, Liang Y.   +9 more
europepmc   +1 more source

Chronic lymphocytic leukemia with IGH::BCL3‐translocation is characterized by a homogeneous and distinct genetic and epigenetic landscape

HemaSphere, Volume 10, Issue 5, May 2026.
Abstract Approximately 1% of chronic lymphocytic leukemia (CLL) cases harbor a translocation juxtaposing the immunoglobulin heavy chain (IGH) and B‐cell lymphoma 3 (BCL3) loci. Aiming at comprehensive molecular characterization of IGH::BCL3‐positive B‐cell neoplasms, we here investigated samples from 84 patients using fluorescence in situ hybridization
Cosima Drewes, Cristina López, Juan Emilio Martinez‐Manjón, Nnamdi Okeke, Billy Jebaraj, Susanne Bens, Björn Brändl, Martin J. S. Dyer, Barbara Eichhorst, Anja Fischer, Kirsten Fischer, Sandra Robrecht, Michael Hallek, Selina Glaser, Sina Hillebrecht, Sandrine Jayne, Helene Kretzmer, Anja Mottok, Franz‐Josef Müller, Christof Schneider, Ole Ammerpohl, Coral del Val, Stephan Stilgenbauer, Eugen Tausch, Reiner Siebert   +24 more
wiley   +1 more source

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis. [PDF]

Biomark Res
Angotzi F, Bevilacqua A, Serafin A, Danesin N, Cellini A, Leone G, D'Antiga M, Pagnin E, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A.   +12 more
europepmc   +1 more source

CRISPR Genome Editing and the Future of Leukaemia Immunotherapy

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Leukaemia presents ongoing therapeutic challenges due to relapse and toxicity associated with standard treatments. By enabling more targeted and safer therapies, CRISPR genome editing is emerging as a powerful tool to address these issues.
Dejin Rai, Umberto Terranova
wiley   +1 more source

Acute Acalculous Cholecystitis Mimicry: Symptomatic Hepatic Infiltration From Chronic Lymphocytic Leukemia Presenting as Cholestatic Liver Injury. [PDF]

ACG Case Rep J
Alnounou A, Zou H, Boamah H.
europepmc   +1 more source

Direct‐stick embolization to treat hematochezia secondary to rectally metastatic sacral neuroblastoma

JPGN Reports, Volume 7, Issue 2, Page 281-284, May 2026.
Abstract Neuroblastoma is a malignant tumor that is typically treated with a combination of surgery, radiation therapy, chemotherapy, and immunotherapy. However, minimally invasive embolization and chemoembolization present promising new treatment modalities.
Anand Dhatt, Leandro Cardarelli‐Leite, Ravjot Dhatt, Collin Barker, Manraj K. S. Heran   +4 more
wiley   +1 more source

CLL-1: An emerging target for immunotherapy in acute myeloid leukemia. [PDF]

Ann Hematol
Wang Y, Xiao Y.
europepmc   +1 more source

Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications

MedComm, Volume 7, Issue 5, May 2026.
Mutant isocitrate dehydrogenase affects multiple cancer types. Alterations in IDH1 and IDH2 result in abnormal enzyme activity, leading to the overproduction of D‐2‐hydroxyglutarate (D‐2HG). This metabolite disrupts cellular metabolism and epigenetic regulation, driving cancer initiation, progression, and metastasis.
Yuhan Fang, Xiaoqing Wang, Kai Luo, Tikam Chand Dakal, He Bai, Caiming Xu, Guixin Zhang   +6 more
wiley   +1 more source

Short and complex-Telomeres and genomes in CLL. [PDF]

Br J Haematol
Jebaraj BMC, Stilgenbauer S.
europepmc   +1 more source

CLL

Annals of Oncology, 2011
openaire   +2 more sources